OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

5-FU mediated depletion of myeloid suppressor cells enhances T-cell infiltration and anti-tumor response in immunotherapy–resistant lung tumor
Ambily Anna Mathew, Zahara Thaivalappil Zakkariya, Anusha Ashokan, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110129-110129
Closed Access | Times Cited: 17

Showing 17 citing articles:

Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
Shuyan He, Lu Zheng, Chunjian Qi
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 12

Mechanism of 5-fluorouracil induced resistance and role of piperine and curcumin as chemo-sensitizers in colon cancer
Dorothy Bhattacharjya, N Sivalingam
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 5

Myeloid-derived suppressor cells in metabolic and cardiovascular disorders
Jingsheng Yan, Shuai Guo, Jun He, et al.
Trends in Endocrinology and Metabolism (2025)
Closed Access

Advancing Cancer Treatment Through Nanotechnology Driven Immunotherapy for Pancreatic Cancer
Sreejith Thrivikraman Nair, Kaladhar Kamalasanan, Smarakan Sneha, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 20, pp. 18670-18697
Closed Access | Times Cited: 7

Optimization of combined chemoradiotherapy and immunotherapy for locally advanced esophageal cancer
Ke Zhang, Zongchang Nie, Jun Wang, et al.
The Innovation Medicine (2024), pp. 100095-100095
Closed Access | Times Cited: 2

Prolonged Complete Remission Using Tislelizumab for Hepatocellular Carcinoma After Adjuvant Chemotherapy Failure: A Case Report
Xianmin Zhu, Shuang Dong, Jing Tang, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1005-1013
Open Access | Times Cited: 1

High‐Affinity Superantigen‐Based Trifunctional Immune Cell Engager Synergizes NK and T Cell Activation for Tumor Suppression
Yao‐An Yu, Wan‐Ju Lien, Wen‐Ching Lin, et al.
Advanced Science (2024) Vol. 11, Iss. 33
Open Access | Times Cited: 1

Harnessing nucleotide metabolism and immunity in cancer: a tumour microenvironment perspective
Hani Suleiman, Alexandra J Emerson, Peter M. Wilson, et al.
FEBS Journal (2024)
Open Access | Times Cited: 1

The potential of mesenchymal stem cell coexpressing cytosine deaminase and secretory IL18-FC chimeric cytokine in suppressing glioblastoma recurrence
Mojtaba Taheri, Hossein Abdul Tehrani, Sara Amel Farzad, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113048-113048
Closed Access

Predicting the Recurrence of Ovarian Cancer Based on Machine Learning
Lining Zhou, Hong Hong, Fuying Chu, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 1375-1387
Open Access

Role of the TME in immune checkpoint blockade resistance of non-small cell lung cancer
Yuening Dai, Xi Tian, Xuanting Ye, et al.
Cancer Drug Resistance (2024)
Open Access

Page 1

Scroll to top